These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22144115)
21. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519 [TBL] [Abstract][Full Text] [Related]
22. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. Rodolfo M; Luksch R; Stockert E; Chen YT; Collini P; Ranzani T; Lombardo C; Dalerba P; Rivoltini L; Arienti F; Fossati-Bellani F; Old LJ; Parmiani G; Castelli C Cancer Res; 2003 Oct; 63(20):6948-55. PubMed ID: 14583496 [TBL] [Abstract][Full Text] [Related]
23. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. Weiser TS; Guo ZS; Ohnmacht GA; Parkhurst ML; Tong-On P; Marincola FM; Fischette MR; Yu X; Chen GA; Hong JA; Stewart JH; Nguyen DM; Rosenberg SA; Schrump DS J Immunother; 2001; 24(2):151-61. PubMed ID: 11265773 [TBL] [Abstract][Full Text] [Related]
24. Impact of valproic acid on dendritic cells function. Frikeche J; Simon T; Brissot E; Grégoire M; Gaugler B; Mohty M Immunobiology; 2012 Jul; 217(7):704-10. PubMed ID: 22209114 [TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts. Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777 [TBL] [Abstract][Full Text] [Related]
26. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo. Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142 [TBL] [Abstract][Full Text] [Related]
27. Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Goodyear O; Agathanggelou A; Novitzky-Basso I; Siddique S; McSkeane T; Ryan G; Vyas P; Cavenagh J; Stankovic T; Moss P; Craddock C Blood; 2010 Sep; 116(11):1908-18. PubMed ID: 20530795 [TBL] [Abstract][Full Text] [Related]
28. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma. Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731 [TBL] [Abstract][Full Text] [Related]
29. Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber. Slager EH; van der Minne CE; Goudsmit J; van Oers JM; Kostense S; Havenga MJ; Osanto S; Griffioen M Cancer Gene Ther; 2004 Mar; 11(3):227-36. PubMed ID: 14726960 [TBL] [Abstract][Full Text] [Related]
30. Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments. Held G; Matsuo M; Epel M; Gnjatic S; Ritter G; Lee SY; Tai TY; Cohen CJ; Old LJ; Pfreundschuh M; Reiter Y; Hoogenboom HR; Renner C Eur J Immunol; 2004 Oct; 34(10):2919-29. PubMed ID: 15368308 [TBL] [Abstract][Full Text] [Related]
31. Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cells. Muraoka D; Kato T; Wang L; Maeda Y; Noguchi T; Harada N; Takeda K; Yagita H; Guillaume P; Luescher I; Old LJ; Shiku H; Nishikawa H J Immunol; 2010 Sep; 185(6):3768-76. PubMed ID: 20733202 [TBL] [Abstract][Full Text] [Related]
32. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications. Coral S; Sigalotti L; Colizzi F; Spessotto A; Nardi G; Cortini E; Pezzani L; Fratta E; Fonsatti E; Di Giacomo AM; Nicotra MR; Natali PG; Altomonte M; Maio M J Cell Physiol; 2006 Apr; 207(1):58-66. PubMed ID: 16252259 [TBL] [Abstract][Full Text] [Related]
33. The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. Ayyoub M; Taub RN; Keohan ML; Hesdorffer M; Metthez G; Memeo L; Mansukhani M; Hibshoosh H; Hesdorffer CS; Valmori D Cancer Immun; 2004 Aug; 4():7. PubMed ID: 15298487 [TBL] [Abstract][Full Text] [Related]
34. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers. Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376 [TBL] [Abstract][Full Text] [Related]
35. Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts. Takenouchi M; Hirai S; Sakuragi N; Yagita H; Hamada H; Kato K Clin Cancer Res; 2011 May; 17(9):2819-29. PubMed ID: 21357681 [TBL] [Abstract][Full Text] [Related]
36. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice. Johannsen A; Genolet R; Legler DF; Luther SA; Luescher IF J Immunol; 2010 Sep; 185(6):3445-55. PubMed ID: 20733200 [TBL] [Abstract][Full Text] [Related]
37. Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. Noguchi T; Kato T; Wang L; Maeda Y; Ikeda H; Sato E; Knuth A; Gnjatic S; Ritter G; Sakaguchi S; Old LJ; Shiku H; Nishikawa H Cancer Res; 2012 Apr; 72(7):1672-82. PubMed ID: 22318866 [TBL] [Abstract][Full Text] [Related]
38. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472 [TBL] [Abstract][Full Text] [Related]
39. Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells. Hu Y; Cheng SC; Chan KT; Ke Y; Xue B; Sin FW; Zeng C; Xie Y Biochem Biophys Res Commun; 2010 Feb; 392(3):329-34. PubMed ID: 20067767 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells. Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]